INS and Hyperglycemia: Both in humans and in rodents, exendin 9–39 efficiently blocks the effect of GLP-1 on insulin secretion and it has even been shown to induce hyperglycemia despite a compensatory increase in endogenous GLP-1 levels [49, 50].